Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102732 | 12610273 | 2 | F | 2016 | 20160810 | 20160801 | 20160816 | EXP | BR-PFIZER INC-2016362654 | PFIZER | 46.00 | YR | M | Y | 90.00000 | KG | 20160816 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102732 | 12610273 | 1 | PS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 1 TABLET OF 80MG PER DAY | 20825 | 80 | MG | CAPSULE, HARD | |||||||
| 126102732 | 12610273 | 2 | SS | AKINETON | BIPERIDEN HYDROCHLORIDE | 1 | Oral | TWO TABLETS PER DAY,STRENGTH 2 MG | U | 0 | 4 | MG | TABLET | ||||||
| 126102732 | 12610273 | 3 | SS | QUETIAPINE HEMIFUMARATE | QUETIAPINE FUMARATE | 1 | Oral | ONE TABLET (100MG) IN THE MORNING AND ONE TABLET (200MG) AT NIGHT | U | 0 | TABLET | BID | |||||||
| 126102732 | 12610273 | 4 | C | RISPERIDONE. | RISPERIDONE | 1 | TWO TABLETS PER DAY | 0 | 2 | DF | TABLET | ||||||||
| 126102732 | 12610273 | 5 | C | PAMELOR | NORTRIPTYLINE HYDROCHLORIDE | 1 | TWO TABLETS PER DAY | 0 | 2 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126102732 | 12610273 | 1 | Schizophrenia |
| 126102732 | 12610273 | 2 | Schizophrenia |
| 126102732 | 12610273 | 3 | Schizophrenia |
| 126102732 | 12610273 | 4 | Schizophrenia |
| 126102732 | 12610273 | 5 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126102732 | 12610273 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126102732 | 12610273 | Abnormal behaviour | |
| 126102732 | 12610273 | Aggression | |
| 126102732 | 12610273 | Crying | |
| 126102732 | 12610273 | Dysstasia | |
| 126102732 | 12610273 | Eyelid function disorder | |
| 126102732 | 12610273 | Feeling abnormal | |
| 126102732 | 12610273 | Hallucination, auditory | |
| 126102732 | 12610273 | Hypophagia | |
| 126102732 | 12610273 | Insomnia | |
| 126102732 | 12610273 | Movement disorder | |
| 126102732 | 12610273 | Personality disorder | |
| 126102732 | 12610273 | Psychotic disorder | |
| 126102732 | 12610273 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126102732 | 12610273 | 1 | 1999 | 201603 | 0 | |
| 126102732 | 12610273 | 2 | 2016 | 0 | ||
| 126102732 | 12610273 | 3 | 2016 | 0 |